Kataoka, Akemi
Iwamoto, Takayuki
Tokunaga, Eriko
Tomotaki, Ai
Kumamaru, Hiraku
Miyata, Hiroaki
Niikura, Naoki
Kawai, Masaaki
Anan, Keisei
Hayashi, Naoki
Masuda, Shinobu
Tsugawa, Koichiro
Aogi, Kenjiro
Ishida, Takanori
Masuoka, Hideji
Iijima, Kotaro
Kinoshita, Takayuki
Nakamura, Seigo
Tokuda, Yutaka
Funding for this research was provided by:
Japan Society for the Promotion of Science (15H04796)
Article History
Received: 13 September 2016
Accepted: 15 September 2016
First Online: 19 September 2016
Compliance with ethical standards
:
: AT, HK, and HM are affiliated with the Department of Healthcare Quality Assessment at the University of Tokyo, and the department is endowed by Johnson & Johnson K.K., Nipro Corporation, Teijin Pharma Ltd., Kaketsuken K.K., St. Jude Medical Japan Co., Ltd., Novartis Pharma K.K., Taiho Pharmaceutical Co., Ltd., W. L. Gore & Associates, Co., Ltd., Olympus Corporation, and Chugai Pharmaceutical Co., Ltd. The other authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or JBCS and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: The study was approved by the review boards of JBCS. The study used only unidentifiable patient information, and no informed consent was required.
: This article does not contain any studies with animals performed by any of the authors.